|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CELLULAR AND MOLECULAR
Departments of Pharmaceutical/Medicinal Chemistry II (H.P., P.G., A.K., S.D., A.B.) and Pharmacology and Toxicology (R.S.), Institute of Pharmacy, University of Regensburg, Regensburg, Germany
In a steady-state GTPase activity assay, N-[3-(1H-imidazol-4-yl)propyl)]guanidines and NG-acylated derivatives are more potent and efficacious at fusion proteins of guinea pig (gpH2R-Gs
S) than human (hH2R-Gs
S) histamine H2 receptor, coupled to the short splice variant of Gs
, Gs
S. Whereas Ala-271 (hH2R) and Asp-271 (gpH2R) in transmembrane domain 7 were identified to determine the potency differences of guanidine-type agonists, the molecular basis for the efficacy differences remains to be elucidated. A homology model of the gpH2R suggested that an H-bond between Tyr-17 and Asp-271 stabilizes an active receptor conformation of the gpH2R. In the present study, we generated a mutant hH2R-Gs
S with Cys-17
Tyr-17/Ala-271
Asp-271 exchanges (hH2R
gpH2R) that exhibited an enhanced level of constitutive GTPase activity and adenylyl cyclase activity compared with wild-type hH2R-Gs
S and gpH2R-Gs
S. Potencies and efficacies of guanidines and NG-acylguanidines were increased at this mutant receptor compared with hH2R-Gs
S, but they were still lower than at gpH2R-Gs
S, suggesting that aside from Tyr-17 and Asp-271 additional amino acids contribute to the distinct pharmacological profiles of both species isoforms. Another hH2R-Gs
S mutant with a Cys-17
Tyr-17 exchange showed inefficient coupling to Gs
S as revealed by reduced agonist-stimulated GTPase and basal adenylyl cyclase activities. Collectively, our present pharmacological study confirms the existence of an H-bond between Tyr-17 and Asp-271 favoring the stabilization of an active receptor conformation. Distinct potencies and efficacies of agonists and inverse agonists further support the concept of ligand-specific conformations in wild-type and mutant H2R-Gs
S fusion proteins.
Address correspondence to: Dr. Roland Seifert, Department of Pharmacology and Toxicology, University of Regensburg, Universitätsstraße 31, D-93053 Regensburg, Germany. E-mail: roland.seifert{at}chemie.uni-regensburg.de
This article has been cited by other articles:
![]() |
A. Strasser, H.-J. Wittmann, M. Kunze, S. Elz, and R. Seifert Molecular Basis for the Selective Interaction of Synthetic Agonists with the Human Histamine H1-Receptor Compared with the Guinea Pig H1-Receptor Mol. Pharmacol., March 1, 2009; 75(3): 454 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Preuss, P. Ghorai, A. Kraus, S. Dove, A. Buschauer, and R. Seifert Constitutive Activity and Ligand Selectivity of Human, Guinea Pig, Rat, and Canine Histamine H2 Receptors J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 983 - 995. [Abstract] [Full Text] [PDF] |
||||